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An increasing proportion of the childhood population of the UK
are members of diverse ethnic groups. Patterns of childhood
cancer incidence vary between the principal ethnic groups in
Britain (Stiller et al, 1991; Powell et al, 1994). In particular, chil-
dren of South Asian origin have a raised incidence of lymphoma
and a deficit of Wilms’ tumour and soft-tissue sarcoma compared
with White children, while among Black children Wilms’ tumour
is relatively common but Ewing’s sarcoma is virtually never seen.
There is, however, no apparent ethnic variation in childhood
leukaemia incidence in Britain.
Little has been published on the survival rates from cancer of
British children from ethnic minorities. In one small study of
patients entered in national trials for acute lymphoblastic
leukaemia (ALL), the survival rate among children of Asian origin
was lower than among White children with similar clinical prog-
nostic features (Oakhill and Mann, 1983). In the US, survival rates
for Black children with leukaemia have been found to be lower
than those for White children in several studies (Novakovic, 1994;
Pui et al, 1995). Survival rates for childhood cancer in developing
countries are seldom available but in general they appear to be
substantially lower than in Western industrialized countries. The
relative contributions to differences in survival rates of biological
variations in types of childhood cancer between populations and of
differing levels of availability of medical care are unknown.
In this paper we present the results of the first large-scale,
national analysis of survival from childhood cancer in Britain in
relation to ethnic group.
PATIENTS AND METHODS
Survival rates by ethnic group were analysed for children with
cancer who were under the care of members of the United
Kingdom Children’s Cancer Study Group (UKCCSG) at paedi-
atric oncology centres throughout Great Britain. Since the forma-
tion of the UKCCSG in 1977, all children with cancer who were
patients at these centres have been included in the UKCCSG
register. The data include the age and sex of the children and
details of the diagnosis. Since 1981, information on ethnic group
has also been collected. This is classified as White, South Asian
(including Indian, Pakistani, Bangladeshi and East African Asian),
Black (African or Caribbean), East Asian (including Chinese and
Japanese), Middle Eastern (including Arab) and Other (including
combinations of the above).
Follow-up is obtained in several ways. Registrations are linked
with the population-based National Registry of Childhood
Tumours (NRCT), which receives death certificates for all persons
who die in Britain under the age of 20 with a neoplasm coded as
the underlying cause. About 5 years from diagnosis, children in
the NRCT for whom no death certificate has been received are
flagged in the National Health Service Central Registers (NHSCR)
who then notify any further deaths together with embarkations
resulting in loss to follow-up. In this study, flagged patients for
whom no death or embarkation had been notified were assumed 
to be still alive on 31 August 1998. Annual follow-up data for
children who are not already known to have died and have not
been flagged are obtained from the databases of the clinical trials
and studies of the UKCCSG and by direct enquiry to the consul-
tants responsible for their care.
The UKCCSG register included 15 829 children who were
diagnosed with a malignant neoplasm or a non-malignant intracra-
nial or intraspinal tumour during 1981–1996. After excluding 484
children of unknown ethnic group, and 2734 in diagnostic groups
with fewer than five deaths expected among non-White children,
12 611 children in 11 diagnostic groups remained for analysis.
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DOI: 10.1054/ bjoc.1999.1101, available online at http://www.idealibrary.com on Table 1 shows the numbers of children in the series, classified by
ethnic group and by diagnostic group in the International
Classification of Childhood Cancer (Kramarova and Stiller, 1996).
Survival rates were calculated by standard actuarial methods
and differences between survival curves were tested by log-rank
tests. Two sets of analyses were performed. The first compared
White children and those of all other ethnic groups combined. The
second compared survival of children from individual minority
ethnic groups with that of White children. In both sets of analyses,
combinations of diagnostic group and ethnic group for which
fewer than five deaths were expected were excluded. As survival
has improved substantially for most types of childhood cancer
since 1980 (Stiller, 1994) and the distribution of ethnic group
among children with cancer has also changed, calendar period of
diagnosis was allowed for as a stratified variable, grouped as
1981–1986, 1987–1991 and 1992–1996. Survival from ALL is
markedly dependent upon age at diagnosis and white cell count;
age, at least, varies between ethnic groups. Accordingly, further
analyses were done in which these two factors were allowed for as
stratified variables, with age grouped as 0, 1–4 and 5–14 years and
white cell count as under and over 20 ´ 109 l–1 or unknown. Age is
also an important prognostic factor for neuroblastoma and was
again allowed for as a stratified variable, this time grouped as 0,
1–2 and 3–14 years. 
RESULTS
Table 2 shows the actuarial 5-year survival rates for White chil-
dren and those of all other ethnic groups combined in each of the
11 diagnostic groups, separately for patients diagnosed during
1981–1986, 1987–1991 and 1992–1996. Observed and expected
numbers of deaths and the results of a log-rank test are also
presented; these are for the whole period 1981–1996, but allowing
for period of diagnosis. No diagnostic group showed a significant
difference in survival between White and non-White children
overall. Non-White children had a lower survival rate than White
children with ALL – relative risk (RR) of death in minority group
= 1.14; the difference in survival became more marked beyond 5
years after diagnosis (Figure 1). Among children diagnosed during
1987–1991, the non-White group had significantly worse survival
(RR = 1.42, P = 0.023), and allowing for age and white blood
count made little difference to this result (RR = 1.39, P = 0.029).
Survival from astrocytoma was significantly worse among non-
White children diagnosed during 1981–1986 (RR = 3.14, P =
0.0022). Non-White children had a significantly higher survival
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Table 1 Numbers of children included in the survival analyses by ethnic
group and diagnostic group in the International Classification of Childhood
Cancer
White All otherb South Asian Black
ALL 4099 442 281 46
ANLL 805 85 41 10
Hodgkin’s disease 555 98 62 18
NHLa 916 100 58 11
Astrocytoma 938 68 37 10
PNET 636 67 41 10
Neuroblastoma 1126 133 68 19
Wilms’ tumour 998 101 39 33
Osteosarcoma 278 26 14 6
Ewing’s sarcoma 260 26 17 1
Rhabdomyosarcoma 781 73 26 13
aIncluding Burkitt’s and unspecified. bIncluding mixed.
Table 2 Survival of White and non-White children by diagnostic group, 1981–1996
Five-year % survival (SE) 2-sided
1981–1986 1987–1991 1992–1996 O E P-value
ALL White 71 (1.3) 76 (1.2)* 82 (1.3) 1068 1081.8 0.17
Other 74 (4.0) 70 (4.0) 84 (3.0) 122 108.2
ANLL White 30 (2.8) 48 (3.1) 56 (3.3) 446 442.8 0.63
Other 48 (10.9) 54 (10.2) 54 (8.1) 43 46.2
Hodgkin’s disease White 93 (1.8) 94 (2.1) 97 (1.3) 44 43.8 0.98
Other 93 (4.6) 96 (3.5) 97 (2.5) 7 7.2
NHL White 68 (2.7) 76 (2.5) 79 (2.4) 244 247.0 0.52
Other 76 (8.5) 72 (7.5) 59 (14.4) 29 26.0
Astrocytoma White 69 (3.2)* 65 (3.0) 70 (2.5) 298 304.1 0.16
Other 25 (12.5) 69 (11.6) 72 (7.2) 26 19.9
PNET White 53 (3.8) 46 (3.5) 50 (3.6) 338 337.1 0.90
Other 47 (12.9) 35 (11.6) 58 (8.6) 35 35.9
Neuroblastoma White 42 (2.7) 42 (2.4) 55 (3.1) 603 607.9 0.52
Other 46 (7.8) 40 (7.3) 24 (17.7) 73 68.1
Wilms’ tumour White 80 (2.3) 81 (2.1) 77 (2.5) 201 197.5 0.42
Other 84 (6.4) 88 (6.3) 80 (6.4) 17 20.5
Osteosarcoma White 51 (5.4) 56 (5.7) 56 (5.9) 125 126.7 0.55
Other 50 (15.8) 100 58 (13.1) 12 10.3
Ewing’s sarcoma White 44 (4.9)* 69 (5.0) 58 (8.6) 114 109.5 0.14
Other 83 (15.2) 78 (13.9) 70 (14.7) 7 11.5
Rhabdomyosarcoma White 57 (3.1) 61 (3.1) 67 (3.2) 309 311.9 0.55
Other 65 (11.5) 48 (9.3) 62 (10.3) 31 28.1
The expected numbers of deaths and log-rank tests are based on stratified analyses allowing for calendar period of diagnosis O = observed
deaths, E = expected deaths. a P < 0.05 on log-rank test for calendar period.rate than White children with Ewing’s sarcoma diagnosed during
1981–1986 (RR = 0.19, P = 0.033). For most other diagnostic
groups there was little evidence of any variation in survival
between White and non-White children.
Table 3 shows the results of analysing survival rates for children
from individual minority ethnic groups compared with White chil-
dren. The poorer survival of South Asian children (RR = 1.23)
with ALL was of borderline statistical significance; again the
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Figure 1 Actuarial survival of White and non-White children with acute lymphoblastic leukaemia, 1981–1996
Table 3 Survival of children by diagnostic group and ethnic group, 1981–1986
White South Asian Black Middle Eastern East Asian
5 year % survival 5-year % survival 5-year % survival 5-year % survival 5-year % survival
(SE) (SE) 2P (SE) 2P (SE) 2P (SE) 2P
ALL 76 (0.7) 75 (2.7) 0.070 81 (6.2) 0.79 62 (10.1) 0.33 71 (9.4) 0.45
ANLL 45 (1.8) 49 (7.8) 0.90 56 (16.6) 0.47
NHL 74 (1.5) 73 (6.0) 0.99
Astrocytoma 69 (1.6) 59 (8.3) 0.15
PNET 49 (2.1) 43 (8.5) 0.91 56 (16.5) 0.90
Neuroblastoma 46 (1.5) 46 (6.4) 0.69 32 (10.7) 0.013
Wilms’ tumour 80 (1.3) 74 (7.2) 0.40 88 (5.8) 0.48
Osteosarcoma 54 (3.2) 63 (13.1) 0.69
Ewing’s sarcoma 56 (3.2) 76 (10.5) 0.29
Rhabdomyosarcoma 61 (1.8) 64 (9.7) 0.69 58 (14.4) 0.99
The log-rank tests are based on comparisons with White children, allowing for calendar period grouped as 1981–1986, 1987–1991, 1992–1996.difference was almost entirely in survival beyond 5 years after
diagnosis. In a further analysis allowing simultaneously for the
effects of age and white blood count in addition to calendar period,
there was little change in the results (RR = 1.25, P = 0.057).
Black children with neuroblastoma had a lower survival rate
than White children with this tumour (RR = 2.12) and the differ-
ence was highly significant. This was partly accounted for by the
fact that only 2/19 (11%) Black children were aged under 1 year at
diagnosis, compared with 322/1126 (29%) of White children but,
when age was allowed for, the poorer survival of Black children
was still significant (RR = 1.79, P = 0.047).
DISCUSSION
A sizeable proportion of the population of Britain is of minority
ethnic origin, yet there is a surprising lack of published informa-
tion on survival from cancer by ethnic group in Britain (Selby,
1996). Cancer mortality in immigrants to Britain has been studied
(Grulich et al, 1992; Swerdlow et al, 1995) but it is unclear how
much the variations are due to differences in incidence rather than
survival.
Most previous studies of cancer survival in relation to ethnic
group have been carried out in the USA. For children, these have
usually compared the results for ALL, the commonest childhood
cancer, between White and Black patients. The present study is the
first large-scale investigation of survival from cancer by ethnic
group at any age in Britain, and the first multi-centre study
anywhere in the world to consider a wide range of childhood
cancers in addition to ALL.
There was little evidence of any ethnic differences in survival
for most of the diagnostic groups studied. The number of statisti-
cally significant results was no greater than would be expected to
occur by chance among the number of comparisons made.
US cancer registration data consistently show differing patterns
of childhood ALL incidence among Blacks and Whites, with the
early childhood peak of good-prognosis disease being much less
marked in Black children (Parkin et al, 1988). Black children with
ALL treated at St Jude Children’s Research Hospital during
1962–1983 had a much lower survival rate than other, predomi-
nantly White, children but during 1984–1992 there was no differ-
ence in survival rates (Pui et al, 1995); these results were little
changed by adjusting for age and white blood count. In contrast,
population-based data from the SEER Program suggested that the
gap between Black and White children’s survival rates widened
between 1978–1982 and 1983–1987, with survival actually deteri-
orating for blacks in the more recent period (Novakovic, 1994);
the contribution of differences in the age distribution of patients
between the ethnic groups was not assessed. It seems unlikely that
the discrepancy between the two studies can be explained by a
concentration of Black children at non-specialist hospitals with a
very low survival rate, as virtually all American children with ALL
in recent years are believed to have been treated at centres affiliated
to one of the major cooperative trials groups (Ross et al, 1996).
Less has been published on ethnic differences in survival from
other childhood cancers. The St Jude study found relatively little
evidence for differences in survival between ethnic groups for
cancers other than ALL. The lack of significant results may simply
be a consequence of the smaller numbers of cases available for
analysis, though in both studies there was little difference between
ethnic groups in the observed survival rates for several types of
cancer. The lower survival rate we found among Black children
with neuroblastoma has not previously been reported. The higher
survival rate among ethnic minority children (predominantly
South Asian) with Ewing’s sarcoma is also a new finding.
The ethnic group classification used has limitations. The largest
non-White category, South Asian, includes people from diverse
socioeconomic, cultural and religious backgrounds. They, or their
parents, could have been born anywhere in the Indian sub-conti-
nent, East Africa, or Britain. Yet even in this group there were
under 300 children with ALL, by far the commonest cancer in this
study. Use of any more specific classification would have substan-
tially reduced the numbers of children in each group and would
also almost certainly have increased the amount of misclassifica-
tion.
Information on the health of ethnic minority children in Britain
is sparse. The available evidence suggests that overall morbidity
and mortality are higher than in White children (Raleigh and
Balarajan, 1995). Ethnic origin and socio-economic status are
confounded. In a recent study, the use of medical services by chil-
dren and young people did not vary with socioeconomic status but
members of the principal ethnic minority groups were less likely
than White children and young people to use hospital inpatient and
outpatient services, which could imply that they receive a poorer
quality of health care (Cooper et al, 1998). The present study indi-
cates, however, that for cancers that are a principal cause of death
at age 1–14, the survival rate is relatively uniform across ethnic
groups. The main exception is the possibly lower long-term
survival of ethnic minority children with ALL, particularly those
of South Asian origin. Possible explanations might include ethnic
variations in drug metabolism, susceptibility to infection or
compliance with therapy. The previously reported poorer prog-
nosis of Asian children who were included in Medical Research
Council ALL trials was almost entirely attributable to a very much
increased rate of death in remission (Oakhill and Mann, 1983).
Remission status was not recorded in our data.
Survival from ALL among ethnic minority children should
continue to be monitored. If they appear to suffer persistently
lower survival rates, more detailed research will be required to
establish why this should be so and hence to indicate possible
means of eliminating the difference.
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